A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

PHASE2RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

June 27, 2023

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2029

Conditions
Glioblastoma Multiforme
Interventions
BEHAVIORAL

Keto Diet

The experimental intervention includes a strict and controlled diet that manages daily macronutrient breakdown and increases the ratio of dietary fat relative to protein and carbohydrate consumption.

BEHAVIORAL

Standard Anti-Cancer Diet

Dietitian sessions will utilize the American Institute for Cancer Research Food resources and will reference foods low in fats such as fruits, vegetables and whole grains, providing key micronutrients and phytonutrients. Sessions will also focus on dietary support to help decrease any treatment related symptoms.

Trial Locations (5)

27705

RECRUITING

Duke University, Durham

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

90404

RECRUITING

Pacific Neuroscience Institute / Saint John's Cancer Institute, Santa Monica

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Cedars-Sinai Medical Center

OTHER